NCEL

NewcelX Ltd

• NASDAQ·1d ago

  Top Biotech Gainers: TNGX Hits New High, ALVO Moves Closer To FDA Approval, ZVRA, IDYA Turn Heads

• TipRanks·4d ago

  NewcelX Calls June 30, 2026 Shareholders’ Meeting as 2025 Losses Deepen

• TipRanks·05/27 14:42

  NewcelX submits NCEL-101 pre-investigational new drug briefing package to FDA

• TipRanks·05/27 12:29

  NewcelX Files Pre-IND With FDA for NCEL-101 Type 1 Diabetes Cell Therapy

• PUBT·05/27 11:55

  NewcelX submits FDA pre-IND package for NCEL-101 type 1 diabetes trial

• Reuters·05/27 11:55

  NEWCELX AG - TYPE B PRE-IND MEETING WITH FDA SCHEDULED FOR LAST WEEK OF JUNE

• Benzinga·05/27 11:31

  EXCLUSIVE: NewcelX Advances Diabetes Therapy Toward Human Trials With FDA Pre-IND Submission

• TipRanks·05/11 22:55

  NewcelX files to sell 2.26M common shares for holders

• Seeking Alpha·05/01 12:48

  NLS Pharmaceutics GAAP EPS of -$2.16

• Benzinga·04/30 17:05

  12 Health Care Stocks Moving In Thursday's Intraday Session

• TipRanks·04/30 14:03

  NewcelX Posts 2025 Results and Bolsters Funding to Accelerate Type 1 Diabetes Program

• Benzinga·04/30 12:56

  NewcelX FY EPS $(2.16) Up From $(2.43) YoY

• Reuters·04/30 12:15

  NEWCELX REPORTS FINANCIAL RESULTS FOR 2025 AND PROVIDES SHAREHOLDERS WITH UPDATE ON ACCELERATED DEVELOPMENT OF TYPE 1 DIABETES TREATMENT IN COLLABORATION WITH ELEDON PHARMACEUTICALS IN 2026

• Benzinga·04/30 12:01

  EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug

• Benzinga·04/30 12:00

  EXCLUSIVE: NewcelX Expects Expanded Strategic Development Collaborations For Diabetes Drug In 2026